Search results
Results from the WOW.Com Content Network
Saracatinib (AZD-0530) is an experimental drug being developed by AstraZeneca. ... Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; ...
Saracatinib, the first Src inhibitor to show inhibition of the Src pathway in human tumor tissue, has anti-tumor activity alone or in combination with chemotherapeutic agents. [3] Chemical structure of PP1. PP1, PP2 (kinase inhibitor) are both inhibitors of Lck and FynT. [4] [5] Dasatinib [1] [6]
Other tyrosine kinase inhibitor drugs that are in clinical trials include bosutinib, [38] bafetinib, Saracatinib(AZD-0530), XLl-999, KX01 and XL228. [6] HSP90 inhibitor NVP-BEP800 has been described to affect stability of Src tyrosine kinase and growth of T-cell and B-cell acute lymphoblastic leukemias.
Main page; Contents; Current events; Random article; About Wikipedia; Contact us
3932 16818 Ensembl ENSG00000182866 ENSMUSG00000000409 UniProt P06239 P06240 RefSeq (mRNA) NM_001042771 NM_005356 NM_001330468 NM_001162432 NM_001162433 NM_010693 RefSeq (protein) NP_001036236 NP_001317397 NP_005347 NP_001155904 NP_001155905 NP_034823 Location (UCSC) Chr 1: 32.25 – 32.29 Mb Chr 4: 129.44 – 129.47 Mb PubMed search Wikidata View/Edit Human View/Edit Mouse Tyrosin-protein ...
Cancer vaccine could be available by 2030, say scientists behind Covid jab. PA Reporter. October 16, 2022 at 5:59 AM.
1969 13836 Ensembl ENSG00000142627 ENSMUSG00000006445 UniProt P29317 Q03145 RefSeq (mRNA) NM_004431 NM_001329090 NM_010139 RefSeq (protein) NP_001316019 NP_004422 NP_034269 Location (UCSC) Chr 1: 16.12 – 16.16 Mb Chr 4: 141.03 – 141.06 Mb PubMed search Wikidata View/Edit Human View/Edit Mouse EPH receptor A2 (ephrin type-A receptor 2) is a protein that in humans is encoded by the EPHA2 ...
This multi-page article lists pharmaceutical drugs alphabetically by name. Many drugs have more than one name and, therefore, the same drug may be listed more than once. ...